The PD-L1/PD-1 axis is extensively explored in the context of cancer, where tumor cell PD-L1 interacts with T cell PD-1 to limit adaptive anti-tumor immune responses (Figure 6a). This evidence concerns the gene PDCD1 and neoplasm.